Medical cannabis sales begin in Utah

Medical cannabis is called medical marijuana and it is an herbal drug derived from plants of the genus Cannabis that is used as part of the treatment for a specific symptom or disease. Although the term cannabis is referring specifically to the plant genus, it is also used interchangeably with marijuana.

It is described as the crude drug isolated from the plant’s leaves and flowers. Utah’s first medical marijuana dispensary opened Monday as the state begins a gradual rollout of its medical cannabis program. Dragonfly Wellness in Salt Lake City is the first out of the gate. The state’s second dispensary is expected to open later this month. It will be followed by seven more in June and the final five later this year, said Rich Oborn, director of the state’s Center for Medical Cannabis.

Although the term cannabis is referring specifically to the plant genus, it is also used interchangeably with marijuana.

The license of Medical Cannabis

Utah issued 14 dispensary licenses to 10 companies, including three multistate operators:

Bloom Medicinals of Florida.

  • Columbia Care of Illinois.
  • Curaleaf of Massachusetts.

State officials have said they would issue additional licenses if market demand warrants it.

However, demand is expected to be limited, at least initially, because so few health professionals are participating in the program.

Qualifying Conditions Of Medical Cannabis

According to Oborn, 60 physicians are approved to recommend the use of medical marijuana for qualifying conditions that include:

  • Chronic pain.
  • Terminal illness.
  • Cancer.
  • Epilepsy.
  • Post-traumatic stress disorder.
  • Smokable medical marijuana products and MMJ edibles are prohibited, but vaping is legal.
  • HIV or acquired immune deficiency syndrome (AIDS)
  • Alzheimer’s disease
  • Amyotrophic lateral sclerosis
  • Cancer
  • Cachexia

A rare condition or disease t is affecting less than 200,000 individuals in the U.S., as defined in federal law. This is not adequately managed despite treatment attempts using conventional medications or physical interventions. Pain lasting longer than two weeks is not adequately managed, in the qualified medical provider’s opinion. It can despite treatment attempts using conventional medications other than opioids or opiates or physical interventions. The compassionate use board is approving on a case-by-case basis.


John Miller Willson
I am one of the project Head managers of the crew at blunt news. I have worked with various business magazines like Business Today, Business World, Outlook as a freelancer before joining the team. I am an addicted reader of self-help books, fictions, and journals.

Check out our latest